Transdermal Clonidine Patch Use

Safe Use of Transdermal Clonidine Patches in the Management of Childhood Motor and Movement Disorders

BACD has worked with BPNA, APPM and NPPG to produce a position statement on the safe use of transdermal Clonidine patches in the management of childhood motor and movement disorders.

This position statement aims to provide healthcare professionals with pragmatic guidance on the use of transdermal clonidine in children with movement and motor disorders, including recommendations on when it is appropriate to consider initiation of transdermal patches; monitoring and advice to be provided to families and carers; and conversion back to enteral dosing.

Medicines for Children have also produced a leaflet for parents and carers